New insight into how 'tidying up' enzymes work

Mar 28, 2011

A new discovery about how molecules are broken down by the body, which will help pharmaceutical chemists design better drugs, has been made by researchers at the University of Bristol.

Working with Professor Jeremy Harvey and Professor Adrian Mulholland of Bristol's School of Chemistry, Dr Julianna Olah, an EU Marie Curie Fellow in Bristol at the time, studied a class of enzymes – cytochromes P450 – which play an important role in removing molecules from the body.

When a tablet of medicine is taken, the active molecules get absorbed into the bloodstream through the gut and make their way around the body, including to the cells in which they are intended to act; however, it's important they don't stay in the body forever. Enzymes (biological catalysts) help break them down to facilitate excretion.

The cytochromes P450 are a very important class of these 'tidying up' enzymes which have evolved to deal with all 'foreign' compounds that do not get broken down as part of normal metabolism (that is, any compounds which are not proteins, carbohydrates or lipids).

Mainly situated in the liver, the P450 enzymes help remove drug molecules by adding oxygen to them. This process usually works smoothly, but for some molecules, it can lead to oxygenated variants that are toxic. Other molecules are also able to interfere with the normal function of the P450 enzymes.

For these reasons, it is important to be able to understand how a given new molecule, considered for use as a medicine, will react with these enzymes. The Bristol researchers aimed to provide this understanding by modeling the reaction mechanism for interaction between one specific drug (dextromethorphan, a component of some cough syrups) and one P450 variant.

Professor Jeremy Harvey said: "Our calculations showed that the outcome of the oxygen transfer process (that is, which part of dextromethorphan oxygen gets added to) is affected by three factors.

"The first is the way in which the molecule fits into the ('docking'). The second is the intrinsic ability of each part of the molecule to accept . The third is how much each competing oxygen-delivery process is compatible with the shape of the enzyme pocket where the reaction occurs.

"While these first two factors were already known, the third was not. This discovery can help pharmaceutical chemists design new with a better understanding of how they will be broken down in the body."

Explore further: Digestive brilliance of breast milk unravelled

add to favorites email to friend print save as pdf

Related Stories

New research increases understanding of drug metabolism

Mar 17, 2010

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes ...

A molecular switch turns on the flame in 'nature's blowtorch'

May 29, 2008

Uncontrolled reaction of organic compounds with oxygen is easy: we call it fire. But nature often needs to do oxidations very specifically, adding oxygen to a particular carbon atom in a complicated molecule without disturbing ...

Recommended for you

Scientists find clues to cancer drug failure

Mar 02, 2015

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy ...

Oat breakfast cereals may contain a common mold-related toxin

Feb 25, 2015

Oats are often touted for boosting heart health, but scientists warn that the grain and its products might need closer monitoring for potential mold contamination. They report in ACS' Journal of Agricultural and Food Chemistry that s ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.